PTCT
PTC Therapeutics Inc
NASDAQ: PTCT · HEALTHCARE · BIOTECHNOLOGY
$64.55
-8.13% today
Updated 2026-04-29
Market cap
$5.83B
P/E ratio
8.19
P/S ratio
3.37x
EPS (TTM)
$8.58
Dividend yield
—
52W range
$36 – $88
Volume
1.2M
WallStSmart proprietary scores
45
out of 100
Grade: C
Sell
Investment rating
5.3
Growth
C+5.3
Quality
C+6.0
Profitability
B8.7
Valuation
A5/9
Piotroski F-Score
Moderate
0.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$87.93
+36.22%
12-Month target
$64.52
-0.05%
Intrinsic (DCF)
$89.55
Margin of safety
+20.80%
3 Strong Buy5 Buy5 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 39.40% — above average
+ 20.80% below intrinsic value
Risks
- Altman Z 0.22 — distress zone
- Negative free cash flow $-36.65M
- Revenue declining -22.70% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $698.80M | $937.82M | $806.78M | $1.73B | $1.73B |
| Net income | $-559.02M | $-626.60M | $-363.30M | $682.64M | $-134.97M |
| EPS | — | — | — | — | $8.58 |
| Free cash flow | $-509.11M | $-279.04M | $-181.94M | $702.34M | $-36.65M |
| Profit margin | -80.00% | -66.81% | -45.03% | 39.44% | 39.40% |
Peer comparison
Smart narrative
PTC Therapeutics Inc trades at $64.55. representing a P/E of 8.19x trailing earnings. Our Smart Value Score of 45/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 0.22, it sits in the distress. TTM revenue stands at $1.73B. with profit margins at 39.40%. Our DCF model estimates intrinsic value at $89.55.
Frequently asked questions
What is PTC Therapeutics Inc's stock price?
PTC Therapeutics Inc (PTCT) trades at $64.55.
Is PTC Therapeutics Inc overvalued?
Smart Value Score 45/100 (Grade C, Sell). DCF value $89.55.
What is the price target of PTC Therapeutics Inc (PTCT)?
The analyst target price is $87.93, representing +36.2% upside from the current price of $64.55.
What is the intrinsic value of PTC Therapeutics Inc (PTCT)?
Based on our DCF model, intrinsic value is $89.55, a +20.8% margin of safety versus $64.55.
What is PTC Therapeutics Inc's revenue?
TTM revenue is $1.73B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
0.22 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.37x
ROE-7,740.00%
Beta0.55
50D MA$68.16
200D MA$66.15
Shares out0.08B
Float0.07B
Short ratio—
Avg volume1.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—